Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OBIO · against 381 other Healthcare companies of similar size
Ranked #343 of 382 · scores higher than 9% of peers
Bars: peers in each 10-point band of the profitability score45 peers with a profitability score of 0–9, including OBIO · Click a bar to see the companies
Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
| Metric | OBIO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 348 reported | -330.8% | 0.2% | 4% | 33% | |
| Operating marginHigher is better · 353 reported | -181.4% | 2.8% | 14% | 33% | |
| Return on assetsHigher is better · 382 reported | -51.0% | -0.4% | 8% | 33% | |
| Return on equityHigher is better · 361 reported | -397.3% | -1.5% | 2% | Context only | |
| Gross marginHigher is better · 399 reported | 99.5% | 37.1% | 96% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 609M USD | 99 | 91 | |
| 5 | 4.4B CNY (≈$611M) | 98 | 77 | |
| 343 | 357M USD | 8 | 32 | |
| 343 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 172M USD |
| 8 |
| 41 |
| 343 | 264M USD | 8 | 30 |
| 343 | 332M USD | 8 | 35 |
| 343 | 334M USD | 8 | 49 |
| 343 | 303M USD | 8 | 27 |
| 350 | 271M USD | 7 | 14 |
| 350 | 257M USD | 7 | 55 |
| 350 | 475M USD | 7 | 22 |